Cargando…
Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering
Myocardial infarction (MI) is associated with damage to the myocardium which results in a great loss of functional cardiomyocytes. As one of the most terminally differentiated organs, the endogenous regenerative potentials of adult hearts are extremely limited and insufficient to compensate for the...
Autores principales: | Liu, Zhiqiang, Zhou, Jin, Wang, Haibin, Zhao, Mengge, Wang, Changyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376510/ https://www.ncbi.nlm.nih.gov/pubmed/25984325 http://dx.doi.org/10.1186/2050-490X-1-6 |
Ejemplares similares
-
Injectable cardiac tissue engineering for the treatment of myocardial infarction
por: Wang, Haibin, et al.
Publicado: (2010) -
Molecular Imaging of Induced Pluripotent Stem Cell Immunogenicity with In Vivo Development in Ischemic Myocardium
por: Liu, Zhiqiang, et al.
Publicado: (2013) -
Engineered Tissue for Cardiac Regeneration: Current Status and Future Perspectives
por: Li, Junjun, et al.
Publicado: (2022) -
Pluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects
por: Singh, Ratnesh, et al.
Publicado: (2018) -
Efficient Isolation of Cardiac Stem Cells from Brown Adipose
por: Liu, Zhiqiang, et al.
Publicado: (2010)